Filing Details
- Accession Number:
- 0001053369-14-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-31 19:58:59
- Reporting Period:
- 2014-03-27
- Filing Date:
- 2014-03-31
- Accepted Time:
- 2014-03-31 19:58:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465822 | Jeenarine Narine | C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-03-27 | 190,172 | $0.43 | 5,987,556 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 14,887,229 | Indirect | By Epic Investments, LLC |
Footnotes
- Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.